United Therapeutics Corp (NASDAQ:UTHR)

114.06
Delayed Data
As of Apr 20
 +1.07 / +0.95%
Today’s Change
106.30
Today|||52-Week Range
152.55
-22.91%
Year-to-Date
No recent news for United Therapeutics Corp.

Today’s Trading

Previous close112.99
Today’s open113.13
Day’s range112.19 - 114.82
Volume501,383
Average volume (3 months)435,956
Market cap$5.0B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-38.95%
Earnings growth (this year)+24.40%
Earnings growth (next 5 years)-8.70%
Revenue growth (last year)+7.91%
P/E ratio12.3
Price/Sales3.85
Price/Book2.37

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...-0.27-0.83%
GRFSGrifols SA+0.01+0.05%
CTLTCatalent Inc-0.01-0.02%
----
Data as of 4:02pm ET, 04/20/2018

Financials

Next reporting dateApril 26, 2018
EPS forecast (this quarter)$3.34
Annual revenue (last year)$1.7B
Annual profit (last year)$417.9M
Net profit margin24.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts